Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Female Breast Carcinoma”

183 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 183 results

Not applicableStudy completedNCT00043472
What this trial is testing

Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk

Who this might be right for
Breast CancerOvarian Cancer
National Cancer Institute (NCI) 40
Not applicableStudy completedNCT04214210
What this trial is testing

The DIALOGUE Study: Swiss-Korean Billateral Collaboration

Who this might be right for
Hereditary CancerBreast CancerOvarian Cancer
University of Basel 128
Not applicableStudy completedNCT00408681
What this trial is testing

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more
Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00003887
What this trial is testing

Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center
Not applicableStudy completedNCT00609505
What this trial is testing

Telemedicine vs. Face-to-Face Cancer Genetic Counseling

Who this might be right for
Hereditary Breast and Ovarian Cancer SyndromeLynch Syndrome
Duke University 130
Not applicableStudy completedNCT05364138
What this trial is testing

Evaluating Scaleup of an Adapted Breast Cancer Early Diagnosis Program in Rwanda

Who this might be right for
Breast CancerBenign Breast DiseaseCervix Cancer
Brigham and Women's Hospital 2,357
Not applicableStudy completedNCT05162846
What this trial is testing

Michigan Genetic Hereditary Testing (MiGHT)

Who this might be right for
Breast CancerColorectal CancerOvarian Cancer+4 more
University of Michigan Rogel Cancer Center 793
Not applicableActive Not RecruitingNCT04763915
What this trial is testing

Improving Care After Inherited Cancer Testing

Who this might be right for
Inherited Cancer SyndromeProstate CancerColorectal Cancer+2 more
Vanderbilt-Ingram Cancer Center 720
Not applicableUnknownNCT05857111
What this trial is testing

Effectiveness Validation of CELBREA® in Symptomatic Women or With Diagnostic Doubt of Breast Pathology (DETECT-BH)

Who this might be right for
Breast DiseaseBenign Breast DiseaseBreast Cancer
Jose Ignacio Sánchez 255
Not applicableActive Not RecruitingNCT04261972
What this trial is testing

Cell-free DNA in Hereditary And High-Risk Malignancies 1

Who this might be right for
Hereditary Cancer Syndrome
University Health Network, Toronto 1,416
Not applicableUnknownNCT03015376
What this trial is testing

Inherited Susceptible Genes Among Epithelial Ovarian Cancer

Who this might be right for
Ovarian Neoplasm EpithelialHereditary Breast and Ovarian Cancer Syndrome
Peking Union Medical College Hospital 1,000
Not applicableStudy completedNCT00248547
What this trial is testing

Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant

Who this might be right for
Cancer
OHSU Knight Cancer Institute 40
Not applicableActive Not RecruitingNCT03246841
What this trial is testing

Investigation of Tumour Spectrum of Germline Mutations in Breast and Ovarian Cancer Genes.

Who this might be right for
Hereditary Breast and Ovarian CancerMutation
UNICANCER 7,274
Not applicableLooking for participantsNCT04751435
What this trial is testing

Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients

Who this might be right for
Educational Materials for Genetic TestingBreast CancerOvarian Cancer+3 more
Memorial Sloan Kettering Cancer Center 445
Not applicableWithdrawnNCT01558778
What this trial is testing

Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+100 more
Roswell Park Cancer Institute
Not applicableStudy completedNCT00079222
What this trial is testing

Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Cancer
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Looking for participantsNCT07369505
What this trial is testing

Sapu003 in Advanced mTOR-sensitive Solid Tumors

Who this might be right for
Breast Cancer MetastaticRenal Cell Carcinoma (RCC)Neuroendocrine Tumors+2 more
SAPU NANO (US) LLC 27
Early research (Phase 1)Study completedNCT00569283
What this trial is testing

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

Who this might be right for
Cancer
Asan Medical Center 18
Not applicableLooking for participantsNCT07505797
What this trial is testing

ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono Health

Who this might be right for
Breast CancerBenign Breast ConditionBreast Fibroadenoma+6 more
iSono Health, Inc. 800
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Next Page